Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem in Nosocomial and Ventilator-Associated Pneumonia
NCT00502801Phase 2Completed
- Sponsor
- PriCara
- Start
- Aug 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of doripenem in hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), sponsored by PriCara. Started Aug 2007; status: completed.
02
Drugs
doripenem
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00502801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502801.